openPR Logo
Press release

MoBiTec, Germany, Announces Availability of Ebola Virus (EBOV) Real Time RT-PCR Kit

08-22-2014 07:17 PM CET | Health & Medicine

Press release from: MoBiTec GmbH

Generation of standard curve

Generation of standard curve

Ebola hemorrhagic fever (Ebola HF) is a severe, often fatal disease in humans and nonhuman primates, caused by infection with Ebolavirus. The recent Ebola outbreak in West Africa is one of the largest Ebola outbreaks in history.

Ebola is the virus Ebolavirus (EBOV), a viral genus, and the disease Ebola hemorrhagic fever (EHF), a viral hemorrhagic fever (VHF). The virus is named after the Ebola River Valley in the Democratic Republic of the Congo (formerly Zaire), which is near the site of the first recognized outbreak in 1976 at a mission hospital run by Flemish nuns. It remained largely obscure until 1989 when several widely publicized outbreaks occurred among monkeys in the United States.
The virus interferes with the endothelial cells lining the interior surface of blood vessels and with coagulation. As the blood vessel walls become damaged and destroyed, the platelets are unable to coagulate, patients succumb to hypovolemic shock. Ebola is transmitted through bodily fluids, while conjunctiva exposure may also lead to transmission.

EBOV real time RT-PCR kit contains a specific ready-to-use system for the detection of EBOV by RT-PCR (Reverse Transcription Polymerase Chain Reaction) in the real-time PCR system. The master contains a Super Mix for the specific amplification of the EBOV RNA. The reaction is done in one step real time RT-PCR. The first step is a reverse transcription (RT), during which the EBOV RNA is transcribed into cDNA. Afterwards, a thermostable DNA polymerase is used to amplify the specific gene fragments by means of PCR (polymerase chain reaction). Fluorescence is emitted and measured by the real time systems´ optical unit during the PCR. The detection of amplified EBOV DNA fragment is performed in fluorimeter channel FAM with the fluorescent quencher BHQ1. In addition, the kit contains a system to identify possible PCR inhibition by measuring the HEX/VIC/JOE fluorescence of the internal control (IC). An external positive control defined as 1×107copies/ml is supplied which allow the determination of the gene load.

Ebola Virus (EBOV) Real Time RT-PCR Kit, manufactured by MoBiTec's partner company Shanghai ZJ Bio-tech Co., LTD, is available as of now; product code QR-0220-01 (Light Cycler) and QR-0220-02 (non Light Cycler).

MoBiTec GmbH (Goettingen, Germany) is a privately held company (founded in 1987) that offers research tools for molecular and cell biology. Products include DNA vectors for cloning and expression, cell transfection reagents and cell culture tools, immobilized and soluble enzymes, products for genomics and proteomics research, numerous antibodies and recombinant proteins, superior fluorescence reagents and kits, affinity chromatography products, as well as general laboratory equipment.

In parallel to its own product lines, MoBiTec distributes products from international companies in Germany. MoBiTec products are distributed worldwide, in Germany from their home office, in other countries by distributors.

MoBiTec GmbH
Arne Schulz
Lotzestr. 22a
37083 Goettingen, Germany

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release MoBiTec, Germany, Announces Availability of Ebola Virus (EBOV) Real Time RT-PCR Kit here

News-ID: 293909 • Views:

More Releases from MoBiTec GmbH

FerroFarRed - An Ion Indicator for the Specific Detection of Fe2+
FerroFarRed - An Ion Indicator for the Specific Detection of Fe2+
Intracellular Fe2+ can react with hydrogen peroxide, thereby producing the hydroxyl radical, a reactive oxygen species (ROS). Excessive ROS causes oxidative stress, resulting in cancer and neurodegenerative diseases. FerroFarRed (also known as SiRhoNox-1 or ER-SiRhoNox) is a fluorescent probe,manufactured by Goryo Chemical, Japan, distributed in Europe by MoBiTec GmbH, Germany. FerroFarRed specifically detects labile iron (II) ions (Fe2+) and is known to react with Fe2+ only, separately from other metal
TransIT-VirusGEN® Transfection Reagent - Ideal for Recombinant Adeno-associated Virus Production
TransIT-VirusGEN® Transfection Reagent - Ideal for Recombinant Adeno-associated …
TransIT-VirusGEN® Transfection Reagent by Mirus, USA, is designed to enhance delivery of packaging and transfer vectors to adherent and suspension HEK 293 cell types to increase recombinant adeno-associated virus (AAV) and lentivirus production. Adeno-associated virus (AAV) is a nonenveloped, single stranded DNA virus from the Paroviridae family notable for its lack of pathogenicity, low immunogenicity and ability to infect both dividing and quiescent cells. Because AAV is replication-defective in the
Elabscience's Vast Portfolio of Products for Life Science Research Distributed by MoBiTec Germany
Elabscience's Vast Portfolio of Products for Life Science Research Distributed b …
MoBiTec's most recent select partner Elabscience specializes in immunodiagnostic technology for the life science community, offering a complete platform for R&D and manufacture. Elabscience major products cover Proteins, Antibodies, ELlSA Kits, CLIA Kits, Labeling Kits,Biochemical Kits, Cell Lines, and Other Reagents. Elabscience also offers custom services for customers, including Protein Expression and Purification Service, Custom Antibody Service, Custom ELISA Service, Cell Biology Service, Molecular Biology Service, and Whole Research Project Solutions. Every
MoBiTec to Exhibit at Potsdam Days on Bioanalysis 2018, Taking Place in Potsdam, Germany
MoBiTec to Exhibit at Potsdam Days on Bioanalysis 2018, Taking Place in Potsdam, …
The "Potsdam Days on Bioanalysis" provide an excellent platform for researchers, clinicians, and entrepreneurs to discuss diagnostics' hot topics, trends, and recent developments as well as new areas of application and future markets. Often, the implementation of goal-oriented and profitable cooperations is quite a challenge, in particular when it comes to innovative product developments in the fields of diagnostics and analytics. Typically, challenges lie within finding the right cooperation partners, identifying

All 5 Releases


More Releases for Ebola

Ebola Vaccine Market Deep Research 2025-2032 | Ebola vaccine market are Merck an …
Latest Qualitative Research Report on the Ebola Vaccine Market Size 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to 2032. The comprehensive research explores into the evolving Market's dynamics, value chain analysis, prominent investment areas, competitive landscape, drivers and constraints, regional outlook, and key market segments. It's also provides the industry overview with growth analysis and
Ebola Vaccine Market | CanSino Biologics Inc, Johnson & Johnson, Merck,
The global ebola vaccine market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the ebola vaccine market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the
Ebola Virus Vaccine Market 2022 | Detailed Report
The Ebola Virus Vaccine research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market's key players. Furthermore, the report offers insightful market data and information about the Ebola
Ebola Vaccine Market Opportunity Analysis, 2018-2026
Ebola virus disease (EVD) causes viral hemorrhagic fever. It is a life threatening disease, which is spread to humans from animals. Direct contact with body fluids of infected person is one of largest causes of spread of this infection. Symptoms of Ebola disease include high fever, vomiting, sore throat, diarrhea, headache and muscular pain, and in few cases, internal or external bleeding. Although, there is no cure for Ebola virus
Ebola Treatment Market to Develop Rapidly by 2024
Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease which frequently causes lethal haemorrhagic fever in humans. The harmful consequences of Ebola viral infection are that the viruses can be used as potential biological weapon. The symptoms of Ebola viral infection include sudden onset of fever, sore throat, headaches, extreme tiredness, vomiting, skin rash,
Ebola Virus Vaccine Market & Pipeline Insight
Ebola virus infection, which was previously called Ebola hemorrhagic fever was discovered in 1976. The infection caused due to ebola virus originates from four different strains of ebola virus. These viruses generally are known to affect non-human primates, and are transmitted from wild animals to the humans and among the latter, it is known to spread through human-to-human transmission. The natural hosts of ebola virus are Fruit bats, which